Abiraterona acetate in the form of nanoemulsu00e3o and process of obtaining abiraterona acetate in the form of nanoemulsu00e3o

摘要

Summary abiraterona acetate in the form of nanoemulsu00e3o and process of obtaining abiraterona acetate in the form of nanoemulsu00e3o this invention belongs to the technology sector of medicine pFor the treatment of cancer and refers more specifically to new forms of oral administration of the anticancer agent abiraterona acetate.For this purpose, will be developed nanoemulsu00f5es for oral use, systems that allow a significant gain in bioavailability and improve the solubility of the abiraterona acetate.Furthermore, these formulations promote the release of the drug at the site of action.Allowing the quantity daily administered is significantly lower than the currently recommended in the package leaflet in commercial use.With that,The invention represents a significant alternative for the treatment of prostate cancer resistant to castration due to reduction of the cost of treatment from the use of a formulation withSmall amount of abiraterona acetate without loss in relation to its therapeutic action and safety.In this way, the access to the drug will be facilitated to individuals with lower income or places with fewer financial resources for public health.